title: Dry eye syndrome: an update in office management.
abstract: Dry eye syndrome is a multifactorial disease of the ocular surface and tear film that results in ocular discomfort, visual disturbances, and tear instability, with potential damage to the cornea and conjunctiva. Risk factors for dry eye syndrome include age (>50 years old), female sex, environments with low humidity, systemic medications, and autoimmune disorders. There are several treatment options that range from artificial tears to anti-inflammatory and immunosuppressant agents. Treatment of this highly prevalent condition can drastically improve the quality of life of individuals and prevent damage to the ocular surface.
authors.affiliation: Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA
authors.forename: William
authors.initials: W
authors.lastname: Yao
authors.forename: Richard S
authors.initials: RS
authors.lastname: Davidson
authors.forename: Vikram D
authors.initials: VD
authors.lastname: Durairaj
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Gelston
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015352:Dry Eye Syndromes / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D009887:Ophthalmoscopy; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D009883:Ophthalmic Solutions